165 related articles for article (PubMed ID: 24938636)
21. Allogeneic Hematopoietic Cell Transplantation for Children with Sickle Cell Disease Is Beneficial and Cost-Effective: A Single-Center Analysis.
Arnold SD; Jin Z; Sands S; Bhatia M; Kung AL; Satwani P
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1258-65. PubMed ID: 25615608
[TBL] [Abstract][Full Text] [Related]
22. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH
Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314
[TBL] [Abstract][Full Text] [Related]
23. Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease.
Gómez-Almaguer D; Ruiz-Argüelles GJ; del Carmen Tarín-Arzaga L; González-Llano O; Gutiérrez-Aguirre H; Cantú-Rodríguez O; Jaime-Pérez J; Carrasco-Yalán A; Giralt S
Biol Blood Marrow Transplant; 2008 Jan; 14(1):10-5. PubMed ID: 18158956
[TBL] [Abstract][Full Text] [Related]
24. Stable renal function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation.
Pedersen SJV; Monagel DA; Mammen C; Lewis VA; Guilcher GMT; Bruce AA
Pediatr Blood Cancer; 2020 Sep; 67(9):e28568. PubMed ID: 32672896
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic Stem Cell Transplantation in Adult Sickle Cell Disease: Problems and Solutions.
Özdoğu H; Boğa C
Turk J Haematol; 2015 Sep; 32(3):195-205. PubMed ID: 25912490
[TBL] [Abstract][Full Text] [Related]
26. [Autoimmune thyroiditis in childhood].
Fricke-Otto S
Kinderkrankenschwester; 2014 Jul; 33(7):262-4. PubMed ID: 25144958
[No Abstract] [Full Text] [Related]
27. Busulfan, fludarabine, and alemtuzumab conditioning and unrelated cord blood transplantation in children with sickle cell disease.
Radhakrishnan K; Bhatia M; Geyer MB; Del Toro G; Jin Z; Baker C; Harrison L; Morris E; Baxter-Lowe LA; Cairo MS
Biol Blood Marrow Transplant; 2013 Apr; 19(4):676-7. PubMed ID: 23403308
[No Abstract] [Full Text] [Related]
28. The spectrum of autoimmune thyroid diseases (AITD).
Orgiazzi J
Ann Med Interne (Paris); 1999 Jun; 150(4):294-300. PubMed ID: 10519017
[No Abstract] [Full Text] [Related]
29. Haematopoietic progenitor cell transplantation in adults with symptomatic sickle cell disease: the time has arrived.
Cairo MS; Savani BN
Br J Haematol; 2021 Feb; 192(4):678-680. PubMed ID: 33482009
[No Abstract] [Full Text] [Related]
30. Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1.
Marsh RA; Bleesing JJ; Chandrakasan S; Jordan MB; Davies SM; Filipovich AH
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1641-5. PubMed ID: 24923536
[TBL] [Abstract][Full Text] [Related]
31. Allogenic hematopoietic stem cell transplantation in sickle cell disease.
Furstenau DK; Tisdale JF
Transfus Apher Sci; 2021 Feb; 60(1):103057. PubMed ID: 33485798
[TBL] [Abstract][Full Text] [Related]
32. Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation.
Lim Z; Baker B; Zuckerman M; Wade JJ; Ceesay M; Ho AY; Devereux S; Mufti GJ; Pagliuca A
J Infect; 2007 Feb; 54(2):e83-6. PubMed ID: 16806484
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus retinitis after hematopoietic stem cell transplantation with alemtuzumab.
Song WK; Min YH; Kim YR; Lee SC
Ophthalmology; 2008 Oct; 115(10):1766-70. PubMed ID: 18562004
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune thyroid disease in the use of alemtuzumab for multiple sclerosis: a review.
Aranha AA; Amer S; Reda ES; Broadley SA; Davoren PM
Endocr Pract; 2013; 19(5):821-8. PubMed ID: 23757618
[TBL] [Abstract][Full Text] [Related]
35. Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center's experience.
Majumdar S; Robertson Z; Robinson A; Starnes S; Iyer R; Megason G
Bone Marrow Transplant; 2010 May; 45(5):895-900. PubMed ID: 19784079
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune Cytopenias Developing Late Post Alemtuzumab-Based Allogeneic Stem Cell Transplantation: Presentation of Short Case Series from a Transplant Center.
Lloyd R; Nikolousis E; Kishore B; Lovell R; Shankara P; Zeid NA; Horgan C; Panteliadou AK; McIlroy G; Xenou E; Kaparou M; Holder K; Murthy V; Kanellopoulos A
Cell Transplant; 2020; 29():963689720950641. PubMed ID: 32806929
[TBL] [Abstract][Full Text] [Related]
37. Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis.
Daniels GH; Vladic A; Brinar V; Zavalishin I; Valente W; Oyuela P; Palmer J; Margolin DH; Hollenstein J
J Clin Endocrinol Metab; 2014 Jan; 99(1):80-9. PubMed ID: 24170099
[TBL] [Abstract][Full Text] [Related]
38. Loss of donor chimerism in remission after allogeneic stem cell transplantation of T-prolymphocytic leukemia patients following alemtuzumab induction therapy.
Szuszies CJ; Hasenkamp J; Jung W; Koch R; Trümper L; Wulf GG
Int J Hematol; 2014 Nov; 100(5):425-8. PubMed ID: 25258193
[TBL] [Abstract][Full Text] [Related]
39. Alterations of Global DNA Methylation and DNA Methyltransferase Expression in T and B Lymphocytes from Patients with Newly Diagnosed Autoimmune Thyroid Diseases After Treatment: A Follow-Up Study.
Guo Q; Wu D; Yu H; Bao J; Peng S; Shan Z; Guan H; Teng W
Thyroid; 2018 Mar; 28(3):377-385. PubMed ID: 29336230
[TBL] [Abstract][Full Text] [Related]
40. Reduced platelet transfusions and earlier platelet engraftment using alemtuzumab-based conditioning regimen in allogeneic stem cell transplantation.
Neumann T; Schneidewind L; Thiele T; Schulze M; Klenner AF; Busemann C; Pink D; Greinacher A; Dölken G; Krüger WH
J Cancer Res Clin Oncol; 2016 May; 142(5):1091-7. PubMed ID: 26779644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
